Related Experiment Video
Updated: Sep 21, 2025

08:28
Single-molecule Manipulation of G-quadruplexes by Magnetic Tweezers
Published on: September 19, 2017
8.1K
G-Quadruplex-Binding Proteins: Promising Targets for Drug Design
Huiling Shu1, Rongxin Zhang1, Ke Xiao1
1State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
Biomolecules
|May 28, 2022
Summary
G-quadruplexes (G4s) are crucial DNA structures involved in gene regulation. Studying G4-binding proteins offers new therapeutic targets for various human diseases.
Area of Science:
- Molecular Biology
- Genomics
- Biochemistry
Background:
- G-quadruplexes (G4s) are non-canonical secondary nucleic acid structures.
- G4s are abundant in regulatory genomic regions, fulfilling critical genome regulatory functions.
- G4s perform biological functions primarily through interactions with proteins.
Purpose of the Study:
- To review the biological functions and structural properties of G-quadruplex-binding proteins.
- To explore the therapeutic potential of targeting G4-protein interactions.
- To discuss the development of novel medical treatments based on G4-protein interactions.
Main Methods:
- Literature review of biochemical experiments identifying G-quadruplex-binding proteins.
- Analysis of the roles of G4-binding proteins in cellular processes.
- Examination of the association of G4-binding proteins with human diseases.
Main Results:
- Numerous G-quadruplex-binding proteins have been identified.
- These proteins are integral to vital cellular processes like telomere maintenance, DNA replication, and gene transcription.
- G4-binding proteins are implicated in various human diseases.
Conclusions:
- G4-protein interactions are key to understanding genome regulation and disease.
- Targeting G4-binding proteins presents a promising avenue for developing novel therapeutics.
- Further intensive study of these interactions can lead to new medical treatments.
Related Concept Videos
Targets for Drug Action: Overview
7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
Single-Strand DNA Binding Proteins
15.1K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
15.1K
Protein-protein Interfaces
13.8K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.8K
Ligand Binding and Linkage
5.0K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.0K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
G Protein-coupled Receptors
13.7K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.7K

